Celltrion Pharm

068760.KQ

33.70 USD

-0.26

-0.77%

Overview

Last close

33.70 usd

Market cap

1.46B usd

52 week high

93.83 usd

52 week low

30.18 usd

Target price

97.4 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

7.4904

Price/Book Value

5.179

Enterprise Value

1.55B usd

EV/Revenue

4.5167

EV/EBITDA

37.6277

Key financials

Revenue TTM

196.76M usd

Gross Profit TTM

57.90M usd

EBITDA TTM

30.65M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

454.19M usd

Net debt

74.22M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.